Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII
- 1 May 2005
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (5) , 991-1000
- https://doi.org/10.1111/j.1538-7836.2005.01309.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Epitope repertoire of human CD4 T cells on the A3 domain of coagulation factor VIIIJournal of Thrombosis and Haemostasis, 2004
- Recognition of coagulation factor VIII by CD4+ T cells of healthy humansJournal of Thrombosis and Haemostasis, 2003
- Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIIIJournal of Thrombosis and Haemostasis, 2003
- CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia ABlood, 2003
- Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia AThrombosis and Haemostasis, 2003
- Immunology of Factor VIII InhibitorsSeminars in Thrombosis and Hemostasis, 2002
- CD4+ T Cells Specific for Factor VIII as a Target for Specific Suppression of Inhibitor ProductionPublished by Springer Nature ,2001
- High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.Proceedings of the National Academy of Sciences, 1994
- Loss of high‐responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: A report from the multi‐center hemophilia cohort studyAmerican Journal of Hematology, 1993
- Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro culturesCellular Immunology, 1986